AT453655T

Hyaluronic acid oligosaccharide fractions and drugs containing the same

Abstract

The invention claims a is selected from 4 of ~60 sizes of HA the chitosan; Comprising the HA the chitosan, and a specific physical and chemical properties layer; andA comprises a pharmaceutical material. The HA the chitosan of the invention, and a cell death suppressing and cell to inhibitor, and cell and a protective agent (e.g organ. preservative and handled pyridine agent and for processing agent and IL-10 generating agent, or IL-8 inhibitor is) an active ingredient, the time for and), and has high), wherein the is arranged.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

28 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
2000206404JapanA
2000247840JapanA
0105918JapanW

Members28

Family members, oldest first
DocumentOfficeKind
CA2698561A1CanadaA1
WO0204471A1World Intellectual Property Organization (WIPO)A1
AU6947801AAustraliaA
CA2414211A1CanadaA1
EP1300412A1European Patent Office (EPO)A1
CN1440418AChinaA
JPWO2002004471A1JapanA1
EP1300412A4European Patent Office (EPO)A4
US2005090661A1United States of AmericaA1
AU2001269478B2AustraliaB2
AU2006252178A1AustraliaA1
US2007134646A1United States of AmericaA1
CN100369925CChinaC
CN101229186AChinaA
US2008182983A1United States of AmericaA1
US7507723B2United States of AmericaB2
US7601488B2United States of AmericaB2
US2009291914A1United States of AmericaA1
EP1300412B1European Patent Office (EPO)B1
AT453655TThis recordAustriaT
ATE453655T1AustriaT1
DE60140941D1GermanyD1
AU2006252178B2AustraliaB2
CA2414211CCanadaC
US2011224169A1United States of AmericaA1
JP4861596B2JapanB2
CA2698561CCanadaC
US8314079B2United States of AmericaB2